Clinical Trial Update: ONO-4538 Phase I Study in Patients With Advanced Malignant Solid Tumors in Japan [Phase 1]

View source ↗

Summary

Phase I trial update for ONO-4538 in patients with advanced malignant solid tumors conducted in Japan; results completed with results posted in 2020.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Solid Tumor

Drugs mentioned

• ONO-4538

Snippet

Sponsor: Ono Pharmaceutical Co., Ltd. | Conditions: Malignant Solid Tumor | Phase 1 | Status: COMPLETED | Results posted: 2020-10-08